FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2012888087> ?p ?o ?g. }

• W2012888087 endingPage "1567" @default.
• W2012888087 startingPage "1559" @default.
• W2012888087 abstract "Nicks, or missing peptide linkages, have been found in hCG beta-subunit between residues 44 and 45 and between residues 47 and 48. We examined the occurrence and biological and immunological activities of nicked hCG. As shown by sequence analysis, CR127 standard hCG is approximately 20% nicked, half at beta 44-45 and half at beta 47-48. Treatment with human leukocyte elastase increased the extent of nicking of CR127 standard hCG. The longer the incubation of CR127 standard with human leukocyte elastase (0, 2, and 21 h), the greater the extent of nicked hCG (20%, 46%, and 89%). As the extent of nicking increased, the receptor-binding ability diminished, as did the ability to stimulate progesterone production by rat corpus luteal cells in vitro (0.9, 0.74, and 0.29 microgram/microgram hCG, respectively). In a regression analysis, a linear relationship was indicated between the extent of nicking and receptor binding values (97% correlation) and between the extent of nicking and steroidogenic activity in vitro (99% correlation). From the intercepts of the regression lines, it was estimated that nicks reduced receptor binding by 11-fold and reduced the steroidogenic activity of hCG by 5-fold. We examined eight individual hCG preparations, three purified from pregnancy urine, three from urine from patients with hydatidiform mole, and two from urine from women with choriocarcinoma. In descending order, the eight individual hCG preparations were 100%, 100%, 85%, 76%, 42%, 41%, 0%, and 0% intact. Although no correlation was observed between the percent intact and the ability of the eight individual samples to displace 50% [125I]hCG in binding CG/LH receptor (r less than 0.5), a close correlation was noted between the percent intact and the steroidogenic activity in vitro (98% correlation). This separated the effects of nicking on receptor binding and steroidogenic activities and indicated that while multiple factors influence receptor binding, only nicking suppresses the steroidogenic activity of bound hCG. We examined the recognition of nicked hCG molecules by different hCG immunoassays. The Hybritech Tandem assay measured total hCG and did not distinguish nicked and intact hCG molecules (in a regression analysis, immunoactivity vs. percent intact hCG, r less than 0.5). In contrast, the immunometric assay using B109 hCG dimer-specific monoclonal antibody and anti-beta-peroxidase only detected the intact component of hCG (in a regression analysis, immunoreactivity vs. percent intact hCG, 98% correlation). We used these assays together to estimate the percentage of intact hCG and to deduce the extent of nicking.(ABSTRACT TRUNCATED AT 400 WORDS)" @default.
• W2012888087 created "2016-06-24" @default.
• W2012888087 creator A5009622474 @default.
• W2012888087 creator A5017769757 @default.
• W2012888087 creator A5021821969 @default.
• W2012888087 creator A5038622138 @default.
• W2012888087 creator A5052833182 @default.
• W2012888087 creator A5059355586 @default.
• W2012888087 creator A5063630764 @default.
• W2012888087 creator A5081014292 @default.
• W2012888087 date "1991-09-01" @default.
• W2012888087 modified "2023-10-17" @default.
• W2012888087 title "The Heterogeneity of Human Chorionic Gonadotropin (hCG). III. The Occurrence and Biological and Immunological Activities of Nicked hCG*" @default.
• W2012888087 cites W1495042188 @default.
• W2012888087 cites W1575599610 @default.
• W2012888087 cites W172013725 @default.
• W2012888087 cites W1782169062 @default.
• W2012888087 cites W1893651774 @default.
• W2012888087 cites W1967235742 @default.
• W2012888087 cites W1972045336 @default.
• W2012888087 cites W1979271941 @default.
• W2012888087 cites W1983731033 @default.
• W2012888087 cites W1985224329 @default.
• W2012888087 cites W1989272533 @default.
• W2012888087 cites W2015680470 @default.
• W2012888087 cites W2030831472 @default.
• W2012888087 cites W2033765874 @default.
• W2012888087 cites W2036409770 @default.
• W2012888087 cites W2052559143 @default.
• W2012888087 cites W2052790041 @default.
• W2012888087 cites W2053218915 @default.
• W2012888087 cites W2081139481 @default.
• W2012888087 cites W2086043349 @default.
• W2012888087 cites W2091229782 @default.
• W2012888087 cites W2099459434 @default.
• W2012888087 cites W2100837269 @default.
• W2012888087 cites W2101417661 @default.
• W2012888087 cites W2102663829 @default.
• W2012888087 cites W2111817213 @default.
• W2012888087 cites W2119975909 @default.
• W2012888087 cites W2417540838 @default.
• W2012888087 cites W638851631 @default.
• W2012888087 cites W165043031 @default.
• W2012888087 cites W207524893 @default.
• W2012888087 cites W2513633187 @default.
• W2012888087 doi "https://doi.org/10.1210/endo-129-3-1559" @default.
• W2012888087 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1714836" @default.
• W2012888087 hasPublicationYear "1991" @default.
• W2012888087 type Work @default.
• W2012888087 sameAs 2012888087 @default.
• W2012888087 citedByCount "114" @default.
• W2012888087 countsByYear W20128880872012 @default.
• W2012888087 countsByYear W20128880872014 @default.
• W2012888087 countsByYear W20128880872015 @default.
• W2012888087 countsByYear W20128880872016 @default.
• W2012888087 countsByYear W20128880872017 @default.
• W2012888087 crossrefType "journal-article" @default.
• W2012888087 hasAuthorship W2012888087A5009622474 @default.
• W2012888087 hasAuthorship W2012888087A5017769757 @default.
• W2012888087 hasAuthorship W2012888087A5021821969 @default.
• W2012888087 hasAuthorship W2012888087A5038622138 @default.
• W2012888087 hasAuthorship W2012888087A5052833182 @default.
• W2012888087 hasAuthorship W2012888087A5059355586 @default.
• W2012888087 hasAuthorship W2012888087A5063630764 @default.
• W2012888087 hasAuthorship W2012888087A5081014292 @default.
• W2012888087 hasConcept C126322002 @default.
• W2012888087 hasConcept C134018914 @default.
• W2012888087 hasConcept C143228043 @default.
• W2012888087 hasConcept C16685009 @default.
• W2012888087 hasConcept C170493617 @default.
• W2012888087 hasConcept C185592680 @default.
• W2012888087 hasConcept C202751555 @default.
• W2012888087 hasConcept C2775948956 @default.
• W2012888087 hasConcept C2778782382 @default.
• W2012888087 hasConcept C2780026642 @default.
• W2012888087 hasConcept C2780832733 @default.
• W2012888087 hasConcept C51296783 @default.
• W2012888087 hasConcept C55493867 @default.
• W2012888087 hasConcept C71315377 @default.
• W2012888087 hasConcept C71924100 @default.
• W2012888087 hasConcept C86803240 @default.
• W2012888087 hasConceptScore W2012888087C126322002 @default.
• W2012888087 hasConceptScore W2012888087C134018914 @default.
• W2012888087 hasConceptScore W2012888087C143228043 @default.
• W2012888087 hasConceptScore W2012888087C16685009 @default.
• W2012888087 hasConceptScore W2012888087C170493617 @default.
• W2012888087 hasConceptScore W2012888087C185592680 @default.
• W2012888087 hasConceptScore W2012888087C202751555 @default.
• W2012888087 hasConceptScore W2012888087C2775948956 @default.
• W2012888087 hasConceptScore W2012888087C2778782382 @default.
• W2012888087 hasConceptScore W2012888087C2780026642 @default.
• W2012888087 hasConceptScore W2012888087C2780832733 @default.
• W2012888087 hasConceptScore W2012888087C51296783 @default.
• W2012888087 hasConceptScore W2012888087C55493867 @default.
• W2012888087 hasConceptScore W2012888087C71315377 @default.
• W2012888087 hasConceptScore W2012888087C71924100 @default.
• W2012888087 hasConceptScore W2012888087C86803240 @default.
• W2012888087 hasIssue "3" @default.

• next